Abstract Background Interleukin-6 (IL-6) was proposed to be associated with the severity of
coronavirus disease 2019 (COVID-19). The present study aimed to explore the kinetics of IL …

Background: Deficient interferon responses have been proposed as one of the relevant
mechanisms prompting severe manifestations of COVID-19. Objective: To evaluate the …

Background Interleukin-6 (IL-6), a proinflammatory cytokine, has been reported to be
associated with disease severity and mortality in patients with coronavirus disease 2019 …

Coronavirus disease 2019 (COVID‐19) has spread rapidly around the world since its
emergence in humans last December. Previous studies suggested that numerous markers …

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
alsoknownasthe2019novelCoronavirus (2019-nCoV), has caused a recent outbreak of …

Abstract Background Coronavirus disease 2019 (COVID-19) can involve persistence,
sequelae, and other clinical complications that last weeks to months to evolve into long …

Introduction Coronavirus disease 2019 (COVID-19) appeared in China in December 2019
and has spread around the world. High Interleukin-6 (IL-6) levels in COVID-19 patients …

Objective To describe the laboratory parameters and biomarkers of the cytokine storm
syndrome associated with severe and fatal COVID-19 cases. Methods A search with …

Abstract Aims SARS-CoV-2, an infectious agent behind the ongoing COVID-19 pandemic,
induces high levels of cytokines such as IL-1, IL-2, IL-4, IL-6, IL-10, TNF-α, IFN-γ etc in …

Purpose Cytokines are major mediators of COVID-19 pathogenesis and several of them are
already being regarded as predictive markers for the clinical course and outcome of COVID …